New shot may protect breast cancer patients from dangerous infection after chemo
Disease control
Ongoing
This study tests a new drug (PEG-G-CSF) to prevent neutropenia, a condition where white blood cells drop dangerously low after chemotherapy. About 250 female breast cancer patients will receive either the new drug or an existing one to compare safety and effectiveness. The goal i…
Phase: PHASE3 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 12:58 UTC